Merck Execs Protected in Case of Takeover
419957
Merck &amp; Co. Inc. has adopted a severance benefits plan aimed at protecting key managers in the event the company is taken over -- a growing possibility since the withdrawal of arthritis drug Vioxx sent shares tumbling.
246189
Private equity firm The Carlyle Group is mulling a bid for the generics business of Germany's Merck KGaA , a unit worth at least 4 billion euros ($5.3 billion), a source close to the process said.
471781
The company is ready to handle competition from generics.
453249
Law &amp; Order: Pharmaceutical Unit. Merck (nyse: MRK - news - people ) Chief Executive Raymond V. Gilmartin may testify in some of the many lawsuits filed over the Vioxx recall, a company lawyer said.
4532
Merck &amp; Co. faces a dual threat from health insurers and patients&#39; lawyers, after a US study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
328935
SOME of the biggest companies in the drug industry are shivering under an avalanche of bad news. Merck has already been hit hard by the withdrawal of Vioxx, its arthritis drug.
266812
Merck & Co. Inc. Chief Executive  Officer Raymond Gilmartin and FDA officials have been called to  testify before Congress on Nov. 18 over safety problems with  the company's withdrawn arthritis drug Vioxx, a top U.S.  lawmaker said on Wednesday.
279929
With its stock down sharply and its ability to thrive as an independent company uncertain, Merck has adopted a special plan that will give its top executives big bonuses if the company is taken over.
151076
Raymond V. Gilmartin, the top executive at troubled pharmaceutical giant Merck &amp; Co. , could testify as soon as March in some of the dozens of lawsuits filed in New Jersey over Merck's withdrawal of its blockbuster arthritis drug Vioxx.
414077
NEW YORK -- Merck &amp; Co.'s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified last week, as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday. That follows several television appearances, as well as testimony before Congress by the company's chief executive.
728288
Merck & Co. Inc. MRK.N, whose shares  have tumbled since the withdrawal of its blockbuster arthritis  drug Vioxx, said on Monday it has adopted a severance benefits  plan aimed at protecting key managers in the event the company  is taken over or liquidated.
480765
Sarbanes-Oxley is meant to protect shareholders, right?
541938
Merck & Co. faces a dual threat from health insurers and patients' lawyers, after a U.S. study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
470953
Merck &amp; Co., seeking to keep managers from leaving after the withdrawal of its Vioxx painkiller, adopted a plan to give severance payments to more than 200 executives should control of the company change.
23358
Private equity firm The Carlyle Group  is mulling a bid for the generics business of Germany's Merck  KGaA , a unit worth at least 4 billion euros ($5.3  billion), a source close to the process said.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
596432
Justice Department prosecutors and Securities and Exchange Commission regulators are investigating Merck &#38; Co. for its handling of the painkiller Vioxx, the pharmaceutical giant disclosed yesterday.